FDA Issues Policies to Guide Medical Product Developers Addressing Virus Variants
The U.S. Food and Drug Administration (FDA) has issued guidances for medical product developers, specifically covering vaccines, diagnostics and...
What Does Digitalization Really Mean to Drug Substance Manufacturing? A Case Study
Introduction
Advanced data analytics tools are used throughout the biopharmaceutical industry, from leveraging computational biology for drug...
Single-Use Systems Underline the Rising Significance of Extractables and Leachables Studies
Examining extractables and leachables is an important safety issue as these substances can adversely impact the health of patients. While...
Thermo Fisher Launches Offering to Facilitate cGMP-Compatible Cell, Gene Therapy Manufacturing
Thermo Fisher Scientific announces the launch of a compliance and services portfolio, compatible with current Good Manufacturing Practice (cGMP)...
Granules Issues Recall of Metformin Hydrochloride Extended-Release Tablets
Granules Pharmaceuticals is voluntarily recalling twelve (12) lots of Metformin Hydrochloride Extended-Release Tablets USP, 750 mg, 100 and 500...
Mylan Initiates Recall of One Lot of Daptomycin for Injection
Mylan announced its U.S.-based Mylan Institutional business is conducting a voluntary nationwide recall to the consumer level of one lot of...
FDA Authorizes Additional COVID-19 Combination Test Ahead of Flu Season
The U.S. Food and Drug Administration (FDA) further assisted health care providers around the country prepare for the upcoming flu season during...
Centogene Receives EUA for COVID-19 Molecular Diagnostic Test
Centogene announced the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for the company's SARS-CoV-2 RT-PCR...



